Levofloxacin is as effective as trimethoprim-sulfamethoxazole for the treatment of pertussis: A prospective observational study

甲氧苄啶 左氧氟沙星 磺胺甲恶唑 观察研究 医学 内科学 抗生素 微生物学 生物
作者
Chuning Wang,Jingjing Li,Hailing Chang,He Tian,Jiehao Cai,Mingliang Chen,Zhongqiu Wei,Mei Zeng
出处
期刊:Journal of Microbiology Immunology and Infection [Elsevier BV]
卷期号:59 (1): 117-123 被引量:6
标识
DOI:10.1016/j.jmii.2025.08.023
摘要

PURPOSE: To evaluate the effectiveness and safety of oral levofloxacin verse trimethoprim-sulfamethoxazole (TMP-SMX) for the treatment of macrolides-resistant pertussis in pediatric outpatients. METHODS: A prospective observational study was conducted at a pediatric pertussis outpatient clinic during the pertussis outbreak in 2024. For eligible children with PCR-confirmed pertussis, administration of either levofloxacin (8-10 mg/kg/dose, once or twice daily) or TMP-SMX (4-20 mg/kg/dose, twice daily) depended on parents' preference. Effectiveness and safety were evaluated for the 5-14 days duration of levofloxacin and TMP-SMX treatment in terms of alleviation of cough symptoms, bacteriologic clearance of Bordetella pertussis and adverse effects. RESULTS: Among 193 enrolled pertussis cases, eighty-four (43.53 %) received levofloxacin and 109 (56.48 %) received TMP-SMX. After completing treatment, paroxysmal cough resolved or improved in 96.43 % of levofloxacin group and 94.50 % (103/109) of TMP-SMX group (p = 0.554). Nocturnal cough resolved or improved in 98.81 % of levofloxacin group and in 98.17 % of TMP-SMX group (p = 0.057). There was no significant difference in bacteriologic clearance rate between levofloxacin group and TMP-SMX group determined by PCR (92.00 % vs 87.06 %, p = 0.378) and culture (100 % vs 100 %, p > 0.378). Symptom resolution rate did not differ significantly among patients treated for 5 or 7 days with either levofloxacin or TMP-SMX. Adverse events were reported in 9.2 % of TMP-SMX-treated patients and 2.4 % of levofloxacin-treated patients (p < 0.05). Drug rash was reported in nine (8.26 %) TMP-SMX-treated patients. CONCLUSIONS: Oral levofloxacin showed a comparable clinical effectiveness and a favorable safety profile to TMP-SMX for the treatment of non-severe pertussis with a 5-7 days course in children.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
无限玉米完成签到,获得积分10
刚刚
迷人雪珊完成签到 ,获得积分10
1秒前
fantasy的应助被Pan采纳,获得10
2秒前
认真芷容发布了新的文献求助10
3秒前
4秒前
吴丹完成签到,获得积分10
4秒前
星辰大海的应助被易博采纳,获得10
4秒前
科研通AI6.4的应助被zyy采纳,获得10
5秒前
搜集达人的应助被白华苍松采纳,获得10
5秒前
5秒前
12完成签到,获得积分10
6秒前
6秒前
JAY完成签到,获得积分10
6秒前
老汉憨憨完成签到,获得积分20
6秒前
Jason发布了新的文献求助10
6秒前
赘婿的应助被王士钰采纳,获得10
6秒前
6秒前
XiaoJiang完成签到,获得积分10
7秒前
852的应助被鲤鱼鑫磊采纳,获得10
7秒前
汉堡包的应助被Xk采纳,获得10
8秒前
Akim的应助被Xk采纳,获得10
8秒前
8秒前
9秒前
9秒前
NexusExplorer的应助被现代的代丝采纳,获得10
10秒前
闪闪兰发布了新的文献求助10
10秒前
11秒前
13秒前
啵子发布了新的文献求助10
14秒前
Situlandon完成签到,获得积分10
14秒前
奈者CO完成签到,获得积分10
14秒前
14秒前
YK完成签到,获得积分10
14秒前
JF123_发布了新的文献求助10
14秒前
123发布了新的文献求助10
15秒前
yanchen发布了新的文献求助10
15秒前
16秒前
小马甲的应助被花样年华采纳,获得10
16秒前
CodeCraft的应助被合适的安梦采纳,获得10
16秒前
whisper完成签到,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187362
求助须知:如何正确求助?哪些是违规求助? 9575478
关于积分的说明 21841431
捐赠科研通 7785067
什么是DOI,文献DOI怎么找? 3434943
关于科研通互助平台的介绍 2559401
邀请新用户注册赠送积分活动 2481820